Quisinostat

Quisinostat (JNJ-26481585) is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7.

Price Not Available 1 mg Quisinostat Supplier Page

Catalog Number	T6055
Alternative Name(s)	JNJ-26481585
Research Area	Apoptosis\|\|\|Autophagy\|\|\|DNA Damage/DNA Repair\|\|\|Chromatin/Epigenetic
Molecular Formula	C21H26N6O2
CAS#	875320-29-9
SMILES	Cn1cc(c2ccccc12)CNCC1CCN(CC1)c1ncc(cn1)C(=O)NO
Size	1 mg
Supplier Page	https://www.targetmol.com/compound/Quisinostat
Additional Information	https://www.targetmol.com/datasheet/T6055